Back to results
US 2005/0233443 A1Published application
Restenosis therapy using mesenchymal stem cells
OwnerToby Freymaninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating restenosis using mesenchymal stem cells, and in particular to treating restenosis following vascular surgery (e.g., angioplasty, stent implantation, rotoblation, atheroectomy, thrombectomy, or grafting).
Claims21
A method for reducing restenosis of a blood vessel, comprising administering a therapeutic amount of mesenchymal stem cells to a patient at risk for developing restenosis.
A method for diminishing restenosis in an angioplasty patient, comprising administering a therapeutic amount of mesenchymal stem cells to the angioplasty patient.
Dependencies are inferred from the claim text.